The results of a study presented at the Annual European Congress of Rheumatology (EULAR 2018) examined rates of malignancy in
Continue reading »
Lifestyle counseling program may reduce risk of certain cancers
A 5-year healthy lifestyle counseling program for adult men was linked with a reduced risk of developing cancers related to
Continue reading »
‘BioSimilar’ drug approved to treat certain types of anemia
(HealthDay)—Retacrit (epoetin alfa-epbx) has been approved by the U.S. Food and Drug Administration as the first “biosimilar” to the anemia
Continue reading »
Males with BRCA mutations have increased risk of certain cancers
(HealthDay)—Males with BRCA mutations have increased incidence of malignant disease, specifically prostate, melanoma, pancreas, and breast cancers, according to a
Continue reading »